Pathogenesis of cholestatic liver disease and therapeutic approaches

Gideon M. Hirschfield, E. Jenny Heathcote, M. Eric Gershwin

Research output: Contribution to journalArticlepeer-review

172 Scopus citations


Cholestatic liver disorders are caused by genetic defects, mechanical aberrations, toxins, or dysregulations in the immune system that damage the bile ducts and cause accumulation of bile and liver tissue damage. They have common clinical manifestations and pathogenic features that include the responses of cholangiocytes and hepatocytes to injury. We review the features of bile acid transport, tissue repair and regulation, apoptosis, vascular supply, immune regulation, and cholangiocytes that are associated with cholestatic liver disorders. We now have a greater understanding of the physiology of cholangiocytes at the cellular and molecular levels, as well as genetic factors, repair pathways, and autoimmunity mechanisms involved in the pathogenesis of disease. These discoveries will hopefully lead to new therapeutic approaches for patients with cholestatic liver disease.

Original languageEnglish (US)
Pages (from-to)1481-1496
Number of pages16
Issue number5
StatePublished - Nov 2010


  • Cholestasis
  • Primary Biliary Cirrhosis
  • Primary Sclerosing Cholangitis
  • Ursodeoxycholic Acid

ASJC Scopus subject areas

  • Gastroenterology


Dive into the research topics of 'Pathogenesis of cholestatic liver disease and therapeutic approaches'. Together they form a unique fingerprint.

Cite this